As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.
19 Analysts have issued a Structure Therapeutics forecast:
19 Analysts have issued a Structure Therapeutics forecast:
Jun '25 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | - - |
-
|
|
EBITDA | -219 -219 |
79%
79%
|
EBIT (Operating Income) EBIT | -220 -220 |
79%
79%
|
Net Profit | -179 -179 |
78%
78%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company engaged in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in San Francisco, CA.
Head office | Cayman Islands |
CEO | Raymond Stevens |
Employees | 199 |
Founded | 2019 |
Website | structuretx.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.